Sana Biotechnology, Inc. (SANA) stock
SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.85−0.03 (-1.60%)
Close on Nov 18, 2026Market cap $553.82MP/E –Yield –
Sana Biotechnology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sana Biotechnology's price to book ratio was 4.4× on Nov 11, 2026, against 5.8× a year earlier. Over the last 5 years it ranged from 1.2× to 9.3×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.4× | −1.0 |
| 2025 | Dec 31, 2025 | 5.5× | +4.2 |
| 2024 | Dec 31, 2024 | 1.2× | −1.0 |
| 2023 | Dec 29, 2023 | 2.2× | +0.9 |
| 2022 | Dec 30, 2022 | 1.3× | −2.1 |
| 2021 | Dec 31, 2021 | 3.4× | – |
See a number that looks wrong?